Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Burz

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Medicine and Pharmacy Reports|September 5, 2022
Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic reviewDaniel Sur, Andrei Havasi, Cristian Virgil Lungulescu, et al.
Cancers|July 27, 2024
The Importance of Extracellular Vesicle Screening in Gastric Cancer: A 2024 UpdateVasile Bintintan, Claudia Burz, Irena Pintea, et al.
Diagnostics (Basel, Switzerland)|June 27, 2024
Predictive Factors of Immunotherapy in Gastric Cancer: A 2024 UpdateVasile Bintintan, Claudia Burz, Irena Pintea, et al.
Gastroenterology Research|December 10, 2016
Molecular Markers in the Pathogenesis of Cholangiocarcinoma: Potential for Early Detection and Selection of Appropriate TreatmentCornelia Braicu, Claudia Burz, Ioana Berindan-Neagoe, et al.
Oncotarget|June 1, 2018
Circulating tumor cells in clinical research and monitoring patients with colorectal cancerClaudia Burz, Vlad-Vasile Pop, Rares Buiga, et al.
Journal of Personalized Medicine|January 27, 2026
Baseline and Dynamic Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Metastatic Colorectal Cancer Patients Treated with PanitumumabTeodor Marian Vancea, Andrada Olivia Tapirdea, Mihai Gabriel Zait, et al.
Life (Basel, Switzerland)|February 25, 2022
Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint BlockadeAlecsandra Gorzo, Diana Galos, Simona Ruxandra Volovat, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
A New Medical Evaluation for Gastric Cancer Patients to Increase the Success Rate of Immunotherapy: A 2024 UpdateGabriel Samasca, Claudia Burz, Irena Pintea, et al.
Gastroenterology Research|December 13, 2016
Hepatocellular Carcinoma: Tumorigenesis and Prediction MarkersCornelia Braicu, Claudia Burz, Ioana Berindan-Neagoe, et al.
Maedica|May 4, 2017
An Invasive Treatment of Pseudomyxoma Peritonei with Intrathoracic InvolvementRami Ababneh, Pompiliu Piso, Hans-Stefan Hofmann, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Medicine and Pharmacy Reports|September 5, 2022
Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic reviewDaniel Sur, Andrei Havasi, Cristian Virgil Lungulescu, et al.
Cancers|July 27, 2024
The Importance of Extracellular Vesicle Screening in Gastric Cancer: A 2024 UpdateVasile Bintintan, Claudia Burz, Irena Pintea, et al.
Diagnostics (Basel, Switzerland)|June 27, 2024
Predictive Factors of Immunotherapy in Gastric Cancer: A 2024 UpdateVasile Bintintan, Claudia Burz, Irena Pintea, et al.
Gastroenterology Research|December 10, 2016
Molecular Markers in the Pathogenesis of Cholangiocarcinoma: Potential for Early Detection and Selection of Appropriate TreatmentCornelia Braicu, Claudia Burz, Ioana Berindan-Neagoe, et al.
Oncotarget|June 1, 2018
Circulating tumor cells in clinical research and monitoring patients with colorectal cancerClaudia Burz, Vlad-Vasile Pop, Rares Buiga, et al.
Journal of Personalized Medicine|January 27, 2026
Baseline and Dynamic Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Metastatic Colorectal Cancer Patients Treated with PanitumumabTeodor Marian Vancea, Andrada Olivia Tapirdea, Mihai Gabriel Zait, et al.
Life (Basel, Switzerland)|February 25, 2022
Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint BlockadeAlecsandra Gorzo, Diana Galos, Simona Ruxandra Volovat, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
A New Medical Evaluation for Gastric Cancer Patients to Increase the Success Rate of Immunotherapy: A 2024 UpdateGabriel Samasca, Claudia Burz, Irena Pintea, et al.
Gastroenterology Research|December 13, 2016
Hepatocellular Carcinoma: Tumorigenesis and Prediction MarkersCornelia Braicu, Claudia Burz, Ioana Berindan-Neagoe, et al.
Maedica|May 4, 2017
An Invasive Treatment of Pseudomyxoma Peritonei with Intrathoracic InvolvementRami Ababneh, Pompiliu Piso, Hans-Stefan Hofmann, et al.
Pageof 4